| 标题 |
BMS-986458 a Potential First-in-Class, Highly Selective, Potent and Well Tolerated BCL6 Ligand Directed Degrader (LDD) Demonstrates Multi-Modal Anti-Tumor Efficacy for the Treatment of B-Cell Non-Hodgkin's Lymphoma |
| 网址 | |
| DOI |
10.1182/blood-2024-210951
doi
|
| 其它 |
期刊:Blood 作者:Lynda Groocock; Gauri Deb; Jinyi Zhu; Jim Gamez; Paola Castiglioni; et al 出版日期:2024-12-06 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)